# Effect of Tadalafil on Insulin Secretion and Insulin Sensitivity in Obese Men.

> **NCT02595684** · PHASE4 · COMPLETED · sponsor: **University of Guadalajara** · enrollment: 18 (actual)

## Conditions studied

- Obesity

## Interventions

- **DRUG:** Tadalafil
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02595684
- **Lead sponsor:** University of Guadalajara
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-08
- **Primary completion:** 2015-11
- **Final completion:** 2015-11
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2020-10-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02595684

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02595684, "Effect of Tadalafil on Insulin Secretion and Insulin Sensitivity in Obese Men.". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT02595684. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*